Despite a lackluster Q2 earnings season, 36 companies defied the trend, doubling both sales and profits. Some achieved growth in the thousands of percentage points, driven by strong demand in sectors like pharma and realty. Analysts remain optimistic about a stronger second half of FY25, citing festive demand and rural recovery.
